MLR - PMP 3/6/15
Major averages rose on lighter volume. The US economy continues to sag as first-time jobless claims and factory orders both came in under expectations. The European Central Bank made a formal announcement that it would begin its quantitative easing program Monday. This was met with yawns for the most part as QE in its various forms from various central banks have been part of the landscape since 2009. Markets thus tiptoed higher on light volume as they have done many times before. Nevertheless, QE has kept this bull market going since 2009, and we have yet to see a correction just beyond 10% since late 2012, and beyond 20% since late 2011.
We had a few new actionable names:
Medical system designer Illumina (ILMN) - earnings are accelerating, pretax margin 28.6%, ROE 27.2%, group rank 50.
Drug developer Regeneron Pharmaceuticals (REGN) - pretax margin 41.7%, ROE 52.3%, group rank 1.
Buyable gap ups:
Drug developer Mallinckrodt Public (MNK) - earnings and sales are strongly accelerating, group rank 5. MNK gapped up on news it would be acquiring Ikaria.
This information is provided by Virtue of Selfish Investing, LLC (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing, LLC. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2016 Virtue of Selfish Investing, LLC. All rights reserved.